Vanguard Group Inc Glaukos Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Vanguard Group Inc holds 6,112,219 shares of GKOS stock, worth $546 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,112,219

Previous 5,965,115 2.47%

Holding current value

$546 Million

Previous $587 Million 7.54%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$82.27 - $103.29 $12.1 Million - $15.2 Million	147,104 Added 2.47%	6,112,219 $631 Million
Q1 2025 May 09, 2025	SELL	$96.6 - $161.22 $952,089 - $1.59 Million	-9,856 Reduced 0.16%	5,965,115 $587 Million
Q4 2024 Feb 11, 2025	BUY	$126.42 - $152.67 $12.9 Million - $15.5 Million	101,838 Added 1.73%	5,974,971 $896 Million
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $47.8 Million - $56.9 Million	420,376 Added 7.71%	5,873,133 $765 Million
Q2 2024 Aug 13, 2024	BUY	$89.48 - $118.35 $12.9 Million - $17 Million	143,860 Added 2.71%	5,452,757 $645 Million
Q1 2024 May 10, 2024	BUY	$76.4 - $96.33 $5.51 Million - $6.95 Million	72,159 Added 1.38%	5,308,897 $501 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $195,198 - $279,075	-3,279 Reduced 0.06%	5,236,738 $416 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $1.32 Million - $1.51 Million	-19,090 Reduced 0.36%	5,240,017 $394 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $2.08 Million - $3.26 Million	-45,840 Reduced 0.86%	5,259,107 $375 Million
Q1 2023 May 15, 2023	SELL	$43.88 - $52.48 $1.94 Million - $2.32 Million	-44,278 Reduced 0.83%	5,304,947 $266 Million
Q4 2022 Feb 10, 2023	SELL	$40.82 - $57.75 $1.29 Million - $1.82 Million	-31,495 Reduced 0.59%	5,349,225 $234 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $1.1 Million - $1.37 Million	23,473 Added 0.44%	5,380,720 $286 Million
Q2 2022 Aug 12, 2022	BUY	$34.86 - $63.77 $4.93 Million - $9.02 Million	141,482 Added 2.71%	5,357,247 $243 Million
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $4.4 Million - $5.73 Million	99,170 Added 1.94%	5,215,765 $302 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $7.87 Million - $11.1 Million	195,364 Added 3.97%	5,116,595 $227 Million
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $5.27 Million - $9.36 Million	111,178 Added 2.31%	4,921,231 $237 Million
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $351 Million - $470 Million	4,810,053 New	4,810,053 $408 Million

Others Institutions Holding GKOS

# of Institutions

334

Shares Held

54.1M

Call Options Held

260K

Put Options Held

484K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.25B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Glaukos Corp Transaction History